Literature DB >> 15000839

Bovine and ovine blood mononuclear leukocytes differ markedly in innate immune responses induced by Class A and Class B CpG-oligodeoxynucleotide.

Angelo Mena1, Anil K Nichani, Yurij Popowych, Xenia P Ioannou, Dale L Godson, George K Mutwiri, Rolf Hecker, Lorne A Babiuk, Philip Griebel.   

Abstract

Cytosine-phosphate-guanosine (CpG)-DNA can induce an impressive array of innate immune responses that may directly or indirectly contribute to the clearance of infectious agents. Assays, such as lymphocyte proliferative responses, have been used to demonstrate that the immunostimulatory activity of CpG-DNA is conserved among a broad range of vertebrate species, but no studies have been completed to determine if qualitative differences exist among species for CpG-oligodeoxynucleotide (ODN)-induced innate immune responses. In this study, we assessed the capacity of a Class A (ODN 2216) and a Class B (ODN 2007) CpG-ODN to induce innate immune responses in two closely related species, ovine (n = 28) and bovine (n = 29). The secretion of interferon (IFN)-alpha and IFN-gamma and non-major histocompatability complex (MHC)-restricted cytotoxic activity were assayed with CpG-ODN-stimulated peripheral blood mononuclear cells (PBMC). These investigations revealed significant interspecies and intraspecies variation in the responses. As expected, ODN 2216 was a potent inducer of IFN-alpha secretion by both bovine and ovine PBMC, but ODN 2007 also induced dose-dependent, CpG-specific IFN-alpha secretion by ovine PBMC. In contrast, a significant dose-dependent, CpG-specific IFN-gamma secretion response was only observed following ODN 2216 stimulation of bovine PBMC. Furthermore, both ODN 2216 and ODN 2007 induced CpG-specific non-MHC-restricted cytotoxicity with ovine but not bovine PBMC. Finally, there was not a single assay in which PBMC from all sheep or cattle responded at a detectable level. A striking aspect of these results is that such marked differences in CpG-ODN induced innate responses existed both between and within two closely related species.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15000839     DOI: 10.1089/154545703322460621

Source DB:  PubMed          Journal:  Oligonucleotides        ISSN: 1545-4576


  7 in total

1.  Intranasal treatment with CpG-B oligodeoxynucleotides protects CBA mice from lethal equine herpesvirus 1 challenge by an innate immune response.

Authors:  Seong K Kim; Akhalesh K Shakya; Dennis J O'Callaghan
Journal:  Antiviral Res       Date:  2019-06-25       Impact factor: 5.970

2.  A physical map of a BAC clone contig covering the entire autosome insertion between ovine MHC Class IIa and IIb.

Authors:  Gang Li; Ka Liu; Shasha Jiao; Haibo Liu; Hugh T Blair; Peng Zhang; Xiaoran Cui; Pingping Tan; Jianfeng Gao; Runlin Z Ma
Journal:  BMC Genomics       Date:  2012-08-16       Impact factor: 3.969

3.  The effect of CpG-ODN on antigen presenting cells of the foal.

Authors:  M Julia B F Flaminio; Alexandre S Borges; Daryl V Nydam; David W Horohov; Rolf Hecker; Mary Beth Matychak
Journal:  J Immune Based Ther Vaccines       Date:  2007-01-25

4.  Induction of a systemic antiviral state in vivo in the domestic cat with a class A CpG oligonucleotide.

Authors:  Céline Robert-Tissot; Marina L Meli; Barbara Riond; Regina Hofmann-Lehmann; Hans Lutz
Journal:  Vet Immunol Immunopathol       Date:  2012-08-04       Impact factor: 2.046

5.  Stimulation with a class A CpG oligonucleotide enhances resistance to infection with feline viruses from five different families.

Authors:  Céline Robert-Tissot; Vera L Rüegger; Valentino Cattori; Marina L Meli; Barbara Riond; Peter F Moore; Monika Engels; Marco Franchini; Regina Hofmann-Lehmann; Hans Lutz
Journal:  Vet Res       Date:  2012-08-20       Impact factor: 3.683

6.  Identification of the MicroRNA Repertoire in TLR-Ligand Challenged Bubaline PBMCs as a Model of Bacterial and Viral Infection.

Authors:  Jasdeep Singh; C S Mukhopadhyay; Simarjeet Kaur; Puneet Malhotra; R S Sethi; R K Choudhary
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

7.  Treatment with Class A CpG Oligodeoxynucleotides in Cats with Naturally Occurring Feline Parvovirus Infection: A Prospective Study.

Authors:  Filippo Ferri; Federico Porporato; Francesco Rossi; Daniela Enache; Carolina Callegari; Gabriele Gerardi; Luigi M Coppola; Barbara Contiero; Chiara Crinò; Neda Ranjbar Kohan; Marina L Meli; Hans Lutz; Regina Hofmann-Lehmann; Eric Zini
Journal:  Viruses       Date:  2020-06-12       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.